Blog Archives - SCN2A Australia

Gene editing with CRISPR

David Cunnington
December 26, 2019
Blog
0 Comments

What is CRISPR? How does it work? Is it ready for use in humans? Hear about CRISPR in this episode of the 'Health Report' podcast.

Hot topics in autism research in 2019

David Cunnington
December 25, 2019
Blog
0 Comments

This year has been a big year in autism research, with advances in understanding the biology of autisum using models such as organiods.

Neurons from mice missing SCN2A (right) have signal-receiving branches that are less mature than those in controls (left).

Loss-of-function SCN2A mutations

David Cunnington
October 21, 2019
Blog
0 Comments

The following work from Assistant Prof. Kevin Benders lab was presented on the 20th of October in Chicago, at Neuroscience 2019 held by Society for Neuroscience (SFN). A bit about…

Natural History Study in SCN2A

Kris Pierce
February 10, 2019
Blog
0 Comments

The SCN2A International Natural History Study (NHS) is comprised of clinicians collaborating from multiple academic institutions, including US, European and Australian based clinicians. Dr. Katherine Howell, from the Royal Children's…

The Florey Institute – SCN2A team

Kris Pierce
January 29, 2019
Blog
0 Comments

Today we are introducing the SCN2A research team at the Florey Institute. The team is lead by Prof Steven Petrou, Director of Florey Institute. The team has been developing a…

Welcome to SCN2A Australia

Kris Pierce
January 26, 2019
Blog
0 Comments

Happy Australia Day! Today we launch SCN2A Australia. We look forward to working with families, researchers, clinicians and professional bodies to improve the lives of those who have SCN2A and…

Facebook Posts

SCN2A Australia

2 days ago

JOIN OUR SCN2A TEAM..

Click on the link below to join our team or donate to the SCN2A fundraiser.

We thank the Epilepsy Foundation of Australia for facilitating this fundraiser

We have had to change the way we raise awareness and funds and advocate. We invite you to join us as we 'Walk for Epilepsy' around Australia.

Over 25 days in October, we’ll walk, swim, run and cycle our way to 25,000 kilometres to raise awareness for the 1 in 25 Australians living with epilepsy.

Home isolation has given Australians a new window into what life can be like for people living with epilepsy. Stigma and uncertainty mean many people are forced to stay at home, something Australians are all too familiar with amid the coronavirus pandemic.

Register Now!
That’s why we’re making the Walk for Epilepsy bigger than it’s ever been before - by taking it online. No matter when, where or how you walk, your contribution will go straight towards our target, which covers the 25,000 kilometres that line Australia’s coast.

Set your own goal, team up with family, friends or colleagues and raise vital funds to support people living with epilepsy. Together, we can make sure no one has to go it alone.

For more info, to register or to donate, please click this link: fundraising.epilepsyfoundation.org.au/fundraiser/scn2a

All funds will go towards the mission of our organisation.

#SCN2A #cureSCn2A

SCN2A - Australia, NZ and Asia ... See MoreSee Less

Photo

View on Facebook

SCN2A Australia

7 days ago

Exciting science on SCN2A for gain of function presentations. Prof. Steve Petrou and his team trialed a ASO on mice models and saw positive outcomes

"This study suggests that a human SCN2A (gapmer) ASO could profoundly and safely impact early seizure onset DEE patients and heralds a new era of precision therapy in neurodevelopmental disorders."

#SCN2A #ASO #cureSCN2A The Florey Institute of Neuroscience and Mental Health

#ionis #rogcon ... See MoreSee Less

Antisense oligonucleotide therapy for SCN2A gain-of-function epilepsy

www.biorxiv.org

The clinical spectrum associated with SCN2A de novo mutations (DNMs) continues to expand and includes autism spectrum disorder with or without seizures, in addition to early and late seizure onset dev...

View on Facebook